ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
PROJECTED IMPACT OF PERSONALIZED MRNA NEOANTIGEN CANCER VACCINES IN MEDICARE: A SCENARIO ANALYSIS USING TRIAL EFFICACY AND LINKED DATA POPULATION ESTIMATES
Mar 18, 2026, 21:38 PM -
EARLY EXPERIENCE WITH THE EUROPEAN UNION JOINT CLINICAL ASSESSMENT (EUJCA): IMPLICATIONS FOR ONCOLOGY PRODUCTS
Mar 18, 2026, 21:38 PM -
GLP-1 THERAPY IMPROVES GLYCEMIC CONTROL WITH NO DIFFERENCE IN MEDICAL SPENDING: A REAL-WORLD EFFECTIVENESS STUDY
Mar 18, 2026, 21:38 PM -
EMPIRICAL TIME-SERIES ANALYSES IN THE PAST THREE DECADES 1991-2023 FOR IMMUNE THROMBOCYTOPENIA MEDICATIONS IN THE US MEDICAID PROGRAMS
Mar 18, 2026, 21:38 PM -
PREVALENCE AND HEALTHCARE BURDEN OF COMPLICATED URINARY TRACT INFECTIONS AMONG HOSPITALIZED PATIENTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
LEVERAGING HEALTH INSURANCE DATA FOR ACCELERATED AND TARGETED RECRUITMENT IN CLINICAL TRIALS IN GERMANY
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE HEALTH-RELATED QUALITY OF LIFE BURDEN IN TRIGEMINAL NEURALGIA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
UNDERSTANDING CEA CHARACTERISTICS ASSOCIATED WITH COST-SAVING FINDINGS
Mar 18, 2026, 21:38 PM -
WHEN THE TAIL WAGS THE DOG: RETHINKING PARTITIONED SURVIVAL MODELLING IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
HETEROGENEOUS RESPONSES TO BRAZIL’S PHARMACEUTICAL PRICE CAP REGULATION: EVIDENCE FROM PRIVATE INSURANCES AND THE UNIFIED HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
ACCESS TO HEALTHCARE, UTILIZATION, AND EXPENDITURES AMONG ADULTS WITH DIABETES AND CARDIORENAL COMORBIDITIES
Mar 18, 2026, 21:38 PM -
CHOOSING PUBLIC LLMS AND AI AGENTS FOR PATIENT OUTCOMES RESEARCH: PRACTICAL PROS/CONS AND GOVERNANCE IMPLICATIONS
Mar 18, 2026, 21:38 PM -
COST-CONSEQUENCE ANALYSIS OF UPADACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN COLOMBIA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF PROCALCITONIN-GUIDED ANTIBIOTIC THERAPY IN ADULT PATIENTS WITH ACUTE RESPIRATORY INFECTION IN A COLOMBIAN REFERRAL HOSPITAL
Mar 18, 2026, 21:38 PM -
ESTIMATING PRODUCTIVITY LOSS FROM A SOCIETAL PERSPECTIVE: A PRACTICAL FRAMEWORK USING U.S. PUBLIC-USE DATA
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF INCIDENT BRAIN METASTASES IN MEDICARE BENEFICIARIES WITH ALK+ METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN AND BARRIERS ASSOCIATED WITH EARLY DIAGNOSIS OF BREAST CANCER IN THE UNITED STATES: A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
VALUE-BASED DECISION BOUNDARIES ANALYSIS (VB-DBA): A NOVEL METHOD OF INTEGRATING NETWORK META-ANALYSIS AND COST-EFFECTIVENESS MODELLING TO ESTIMATE PRICING THRESHOLDS BASED ON TARGET PRODUCT PROFILES
Mar 18, 2026, 21:38 PM -
REAL WORLD EVIDENCE FOR LABEL EXPANSION: IDENTIFYING OFF-LABEL USE TRENDS IN THE HOSPITAL SETTING
Mar 18, 2026, 21:38 PM -
COMBINING DISCRETE CHOICE EXPERIMENT AND CONTINGENT VALUATION TO ESTIMATE WILLINGNESS-TO-PAY FOR LYME DISEASE VACCINE ATTRIBUTES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM